Ongoing Clinical Trials definition

Ongoing Clinical Trials means the ongoing clinical studies sponsored or supported by the Seller Group (including post-approval studies) or otherwise recommended by a Governmental Entity, and regulatory commitments in respect of the Products, and “Ongoing Clinical Trial” shall mean any one of them;
Ongoing Clinical Trials means, in respect of a Seller, the ongoing clinical studies sponsored or supported by that Seller’s Group (including post-approval studies) or otherwise recommended by a Governmental Entity in respect of the relevant Products;
Ongoing Clinical Trials has the meaning set forth in Section 5.3.2.

Examples of Ongoing Clinical Trials in a sentence

  • Ongoing Clinical Trials abstracts are embargoed until the date and start time of the Ongoing Cliials Poster Session start time.

  • Safety Surveillance for Ongoing Clinical Trials 9 Because it is critical that a drug product’s risks be adequately assessed during development, sponsors should ensure that they have in place a systematic approach for safety surveillance.

  • The parties shall consult from time to time regarding the use, details and timing of the Ongoing Clinical Trials to support registration filings for the Product in the Territory and in particular for Europe and key countries (e.g. Japan, China, Russia,.Brasil, India, etc).

  • Licensor shall promptly provide the data of the Ongoing Clinical Trials free-of-charge to Licensee and Licensee may rely upon the data from those Ongoing Clinical Trials solely for use with the Product within the Territory.

  • The obligations of the Opt-Out Party pursuant to Sections 3.4, 3.5, 3.6, 3.7 and 3.8 shall survive to the extent applicable to Development Activities conducted by the Opt-Out Party under this Agreement (including, for the avoidance of doubt, activities with respect to Ongoing Clinical Trials as described in this Section 5.3.2), and Article 3 shall otherwise terminate.


More Definitions of Ongoing Clinical Trials

Ongoing Clinical Trials means clinical trials sponsored by Licensor and listed in attached Schedule C (ii) ‘”New Clinical Trials” shall mean any new clinical trials relating to the Product which are initiated by Licensor or Licensee after the Second A&R Agreement Date.
Ongoing Clinical Trials means those clinical trials listed at Exhibit E hereto, which are clinical trials of Infergen that Amgen is conducting in the Territory as of the Effective Date. For avoidance of doubt, Ongoing Clinical Trials shall exclude any Amgen-sponsored investigator-driven clinical trials. Amgen represents that the Ongoing Clinical Trials are the only clinical trials of Infergen being conducted in the Territory by or on Amgen's behalf as of the Effective Date.
Ongoing Clinical Trials means the clinical trials of the Product in the Field in the Territory that are described in Exhibit A hereto.
Ongoing Clinical Trials shall have the meaning given in Section 6.2.
Ongoing Clinical Trials means those clinical trials and clinical studies run by ASLAN which were completed or ongoing as at the Effective Date for the Product, as detailed in Schedule 2.
Ongoing Clinical Trials means (a) [***] in each case as being conducted by iNtRON or its Affiliates as of the Effective Date.
Ongoing Clinical Trials. 3 1.31 "Other Licensee" 3 1.32 "Patent" 3 1.33 "PEG Know-How" 4 1.34 "PEG Patent" 4 1.35 "PEG Program" 4 1.36 "PEG-Infergen Product" 4 1.37 "Phase III Clinical Trial" 4 1.38 "Phase IV Clinical Trial" 4 1.39 "Planning Period Date" 4 1.40 "Regulatory Approval" 4 1.41 "Regulatory Authority" 4 1.42 "Royalty" or Royalties" 4 1.43 "Sublicensee" 4 1.44 "Supply Terms" 4 1.45 "Term" 4 1.46 "Territory" 4 1.47 "Third Party" 4 1.48 "Trademark" 4 1.49 "Valid Claim" 5